237 related articles for article (PubMed ID: 33125116)
21. Down-Regulation of Ubiquitin-Specific Peptidase 9X Inhibited Proliferation, Migration and Invasion of Osteosarcoma via ERK1/2 and PI3K/Akt Signaling Pathways.
Zheng W; Li S; Huang J; Dong Y; Zhang H; Zheng J
Biol Pharm Bull; 2022; 45(9):1283-1290. PubMed ID: 36047196
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of Ski decreases osteosarcoma cell proliferation and migration by suppressing the PI3K/Akt signaling pathway.
Zhao X; Fang Y; Wang X; Yang Z; Li D; Tian M; Kang P
Int J Oncol; 2020 Jan; 56(1):206-218. PubMed ID: 31746363
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of STIP1 regulate apoptosis and invasion of glioma cells via TRAP1/AKT signaling pathway.
Yin H; Deng Z; Li X; Li Y; Yin W; Zhao G; Jiang D; Sun C; Zhou Y
Cancer Genet; 2019 Sep; 237():1-9. PubMed ID: 31447061
[TBL] [Abstract][Full Text] [Related]
24. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
[TBL] [Abstract][Full Text] [Related]
25. LY294002 induces G0/G1 cell cycle arrest and apoptosis of cancer stem-like cells from human osteosarcoma via down-regulation of PI3K activity.
Gong C; Liao H; Wang J; Lin Y; Qi J; Qin L; Tian LQ; Guo FJ
Asian Pac J Cancer Prev; 2012; 13(7):3103-7. PubMed ID: 22994717
[TBL] [Abstract][Full Text] [Related]
26. LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors
Zhang Q; Tang X; Zhou Y; Chen X; Peng K; Jiang R; Liu Z; Song X; Xia H
Cancer Biol Ther; 2023 Dec; 24(1):2198904. PubMed ID: 37211864
[TBL] [Abstract][Full Text] [Related]
27. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
28. PIK3R3, part of the regulatory domain of PI3K, is upregulated in sarcoma stem-like cells and promotes invasion, migration, and chemotherapy resistance.
Yoon C; Lu J; Ryeom SW; Simon MC; Yoon SS
Cell Death Dis; 2021 Jul; 12(8):749. PubMed ID: 34321458
[TBL] [Abstract][Full Text] [Related]
29. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
30. Lupeol suppresses migration and invasion
Hsu MJ; Peng SF; Chueh FS; Tsai CH; Tsai FJ; Huang CY; Tang CH; Yang JS; Hsu YM; Huang WW; Chung JG
Biosci Biotechnol Biochem; 2019 Sep; 83(9):1729-1739. PubMed ID: 31010399
[TBL] [Abstract][Full Text] [Related]
31. SPOP suppresses osteosarcoma invasion via PI3K/AKT/NF-κB signaling pathway.
Chen L; Pei H; Lu SJ; Liu ZJ; Yan L; Zhao XM; Hu B; Lu HG
Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):609-615. PubMed ID: 29461588
[TBL] [Abstract][Full Text] [Related]
32. ZIC2 promotes viability and invasion of human osteosarcoma cells by suppressing SHIP2 expression and activating PI3K/AKT pathways.
Huang S; Jin A
J Cell Biochem; 2018 Feb; 119(2):2248-2257. PubMed ID: 28857346
[TBL] [Abstract][Full Text] [Related]
33. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
[TBL] [Abstract][Full Text] [Related]
34. COX‑2 promotes epithelial‑mesenchymal transition and migration in osteosarcoma MG‑63 cells via PI3K/AKT/NF‑κB signaling.
Zhang X; Qu P; Zhao H; Zhao T; Cao N
Mol Med Rep; 2019 Oct; 20(4):3811-3819. PubMed ID: 31485669
[TBL] [Abstract][Full Text] [Related]
35. Knockdown of UBE2T Inhibits Osteosarcoma Cell Proliferation, Migration, and Invasion by Suppressing the PI3K/Akt Signaling Pathway.
Wang Y; Leng H; Chen H; Wang L; Jiang N; Huo X; Yu B
Oncol Res; 2016; 24(5):361-369. PubMed ID: 27712593
[TBL] [Abstract][Full Text] [Related]
36. GPNMB silencing suppresses the proliferation and metastasis of osteosarcoma cells by blocking the PI3K/Akt/mTOR signaling pathway.
Jin R; Jin YY; Tang YL; Yang HJ; Zhou XQ; Lei Z
Oncol Rep; 2018 Jun; 39(6):3034-3040. PubMed ID: 29620278
[TBL] [Abstract][Full Text] [Related]
37. Knockdown of PREX2a inhibits the malignant phenotype of osteosarcoma cells.
Dai Z; Xie J; Lei P; Hu Y
Mol Med Rep; 2016 Feb; 13(2):1930-6. PubMed ID: 26718453
[TBL] [Abstract][Full Text] [Related]
38. Alantolactone suppresses human osteosarcoma through the PI3K/AKT signaling pathway.
Zhang Y; Weng Q; Han J; Chen J
Mol Med Rep; 2020 Feb; 21(2):675-684. PubMed ID: 31974628
[TBL] [Abstract][Full Text] [Related]
39. Astrocyte elevated gene-1 (AEG-1) promotes osteosarcoma cell invasion through the JNK/c-Jun/MMP-2 pathway.
Wang F; Ke ZF; Wang R; Wang YF; Huang LL; Wang LT
Biochem Biophys Res Commun; 2014 Oct; 452(4):933-9. PubMed ID: 25204501
[TBL] [Abstract][Full Text] [Related]
40. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
